Evidence map›Paper›PMID 22851906›Full record

ArticleArchaea (Vancouver, B.C.)2012

A novel inducible protein production system and neomycin resistance as selection marker for Methanosarcina mazei.

Sebastian Mondorf, Uwe Deppenmeier, Cornelia Welte

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Archaea (Vancouver, B.C.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Valine overproduction inMetabolic engineering communications · 2026
    Article
  2. Article
  3. Teaching old dogs new tricks: genetic engineering methanogens.Applied and environmental microbiology · 2024
    Review
  4. Article
  5. Article
  6. Newly Established Genetic System for Functional Analysis of MetSV.International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Biotechnology of extremely thermophilic archaea.FEMS microbiology reviews · 2018
    Review
  13. Review
  14. sRNARNA biology · 2017
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sebastian MondorfInstitute for Microbiology and Biotechnology, University of Bonn, 53115 Bonn, Germany.
Uwe Deppenmeier
Cornelia Welte
University of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methanosarcina mazei is one of the model organisms for the methanogenic order Methanosarcinales whose metabolism has been studied in detail. However, the genetic toolbox is still limited. This study was aimed at widening the scope of utilizable methods in this group of organisms. (i) Proteins specific to methanogens are oftentimes difficult to produce in E. coli. However, a protein production system is not available for methanogens. Here we present an inducible system to produce Strep-tagged proteins in Ms. mazei. The promoter p1687, which directs the transcription of methyl transferases that demethylate methylamines, was cloned into plasmid pWM321 and its activity was determined by monitoring β-glucuronidase production. The promoter was inactive during growth on methanol but was rapidly activated when trimethylamine was added to the medium. The gene encoding the β-glucuronidase from E. coli was fused to a Strep-tag and was cloned downstream of the p1687 promoter. The protein was overproduced in Ms. mazei and was purified in an active form by affinity chromatography. (ii) Puromycin is currently the only antibiotic used as a selectable marker in Ms. mazei and its relatives. We established neomycin resistance as a second selectable marker by designing a plasmid that confers neomycin resistance in Ms. mazei.

Indexed as

Drug Resistance, MicrobialAffinity LabelsArchaeal ProteinsBiomarkersChromatography, AffinityCloning, MolecularCulture MediaEnzyme ActivationEscherichia coliGenes, BacterialGlucuronidaseMethanolMethanosarcinaMethylaminesMethyltransferasesNeomycinAffinity LabelsArchaeal ProteinsBiomarkersCulture MediaGlucuronidaseMethanolMethylaminesMethyltransferasesNeomycinPuromycinRecombinant Proteinstrimethylamine

Identifiers

PMID22851906
PMCPMC3407599
OpenAlexW2122968266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.